Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease-Reference-Cited by-同舟云学术

Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease

Published:2016-06 Issue:2 Volume:2 Page:121-130
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Koppel Jeremy¹,Jimenez Heidy¹,Adrien Leslie¹,Greenwald Blaine S.²,Marambaud Philippe¹,Cinamon Ezra³,Davies Peter¹

Affiliation:

1. The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute of Medical Research; Northwell Health; Manhasset NY USA

2. The Zucker Hillside Hospital; Northwell Health; Glen Oaks NY USA

3. Rambam Mesivta; Lawrence NY USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.trci.2016.05.003/fullpdf

Reference73 articles.

1. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials;Schneider;Am J Geriatr Psychiatry,2006

2. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial;Sultzer;Am J Psychiatry,2008

3. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis;Maher;JAMA,2011

4. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials;Schneider;JAMA,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competitive Inhibition and Synergistic Effects of Nutraceutical and Metabolite Molecules on Anti-Acetylcholinesterase Activity;Journal of the Turkish Chemical Society Section A: Chemistry;2024-05-15

2. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles;Biomedicine & Pharmacotherapy;2024-02

3. Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology;Nature Mental Health;2024-01-10

4. Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles;2023-09-13

5. The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [11C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease;Biomedicines;2023-07-25